Ann W McMahon

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi request reprint Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003
    Ann W McMahon
    Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Maryland 20852, USA
    Pediatrics 115:453-60. 2005
  2. doi request reprint Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists
    Ann W McMahon
    Office of Pediatric Therapeutics, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD 20993, USA
    Pediatrics 128:e1147-54. 2011
  3. doi request reprint Trends of outpatient prescription drug utilization in US children, 2002-2010
    Grace Chai
    Office of Surveillance and Epidemiology, Division of Epidemiology II, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
    Pediatrics 130:23-31. 2012
  4. ncbi request reprint Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases
    Ann W McMahon
    1401 Rockville Pike, HFM 220, Rockville, MD 20852, USA
    Vaccine 25:1727-34. 2007
  5. doi request reprint Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008
    Ann W McMahon
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA
    Pharmacoepidemiol Drug Saf 19:921-33. 2010

Detail Information

Publications5

  1. ncbi request reprint Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003
    Ann W McMahon
    Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Maryland 20852, USA
    Pediatrics 115:453-60. 2005
    ..In April 2002, the Advisory Committee on Immunization Practices (ACIP) encouraged providers to vaccinate healthy 6- to 23-month-old infants and children with trivalent influenza vaccine (TIV)...
  2. doi request reprint Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonists
    Ann W McMahon
    Office of Pediatric Therapeutics, Office of the Commissioner, Food and Drug Administration, Silver Spring, MD 20993, USA
    Pediatrics 128:e1147-54. 2011
    ..To determine the risk, by age group, of serious asthma-related events with long-acting β(2)-adrenergic receptor agonists marketed in the United States for asthma...
  3. doi request reprint Trends of outpatient prescription drug utilization in US children, 2002-2010
    Grace Chai
    Office of Surveillance and Epidemiology, Division of Epidemiology II, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
    Pediatrics 130:23-31. 2012
    ..To describe trends in outpatient prescription drug utilization in US children and the changes in major areas of pediatric therapeutic use for the years 2002 through 2010...
  4. ncbi request reprint Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases
    Ann W McMahon
    1401 Rockville Pike, HFM 220, Rockville, MD 20852, USA
    Vaccine 25:1727-34. 2007
    ..Laboratory and epidemiological evidence suggests that YEL caused encephalitis. Additional studies will be required to confirm whether YEL can rarely result in GBS and/or ADEM...
  5. doi request reprint Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008
    Ann W McMahon
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA
    Pharmacoepidemiol Drug Saf 19:921-33. 2010
    ..The investigation identified Baxter Healthcare-brand heparin product due to its strongest association with the events. Later, oversulfated chondroitin sulfate (OSCS), a heparin-like contaminant, was discovered...